Recombinant and Designer Therapeutics (Technical Insights)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

The report discusses the latest trends in recombinant and designer therapeutics

Table of Contents

Recombinant and Designer Therapeutics (Technical Insights), Executive SummaryScope and MethodologyScopeMethodologySummary of Industry TrendsKey Technology TrendsFuture TrendsRecombinant and Designer Therapeutics (Technical Insights), Technology AssessmentTechnology PrimerIntroduction to Recombinant and Designer TherapeuticsTypes of Recombinant TherapeuticsDrivers Restraints and ChallengesTechnology DriversRestraints and Challenges Recombinant and Designer Therapeutics (Technical Insights), Analyst Insights on Innovations Strategic Assessment of the Industry-IBroad Strategies Adopted in the Industry and Competitive Positioning of DevelopersPorters Competitive Forces Analysis for the IndustryStrategic Assessment of the Industry-IIAssessment of the External Environment and Internal PotentialAssessment of Internal Environment- Technology SWOT AnalysisCurrent Industry Trends and Implications on Industry PositioningPrincipal Technological DevelopmentsFuture Directions for the Industry and Strategic Overview of CompaniesScenario Analysis for Recombinant Therapeutics IndustryStakeholder Matrix for Therapeutics and Strategic RecommendationsRecombinant and Designer Therapeutics (Technical Insights), Patents and Key Industry ParticipantsPatentsIndustry PatentsAcademic PatentsKey ParticipantsIndustry ParticipantsAcademic ParticipantsRecombinant and Designer Therapeutics (Technical Insights), Decision Support DatabaseDSD tablesNumber of Biotech Companies (Million USD)--World (2004 to 2014)Venture Capital Investment in Biotech R&D (Million USD)--World (2004 to 2014)Government Investment in Biotech R&D (Million USD)--World (2004 to 2014)New Cases of Diabetes --World (2004 to 2014)Total Cancer Cases--World (2004 to 2014)




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.